New findings to be presented at ASCO 2026 suggest GLP-1 medicines may help reduce cancer progression, although experts say more trials are still needed
Often symptomless, fatty liver disease is becoming a leading cause of liver cancer. Learn the role of daily habits, early warning signs, and lifestyle changes that can prevent progression
The development is likely to trigger launch of generic versions by Indian drug majors; this would be a great relief to patients as prices might come down by 25% or so
